Related Articles
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients
Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer
Pain polymorphisms and opioids: An evidence based review
Efficacy and tolerability of oxycodone in moderate-severe cancer‑related pain: Α meta‑analysis of randomized controlled trials
Effect of systemic injection of heterogenous and homogenous opioids on peripheral cellular immune response in rats with bone cancer pain: A comparative study